Lillian Chiang, CEO, presents at BioCentury Conference
Lillian Chiang, Evrys Bio’s CEO, presents at BioCentury’s East-West Biopharma Summit October 2-4 in Boston https://conferences.biocentury.com/east-west-summit
Main Menu
- Home
- Management, Board Members and Advisors
- Platform & Pipeline
- Platform and Pipeline
- An-allosteric-inhibitor-of-sirtuin-2-blocks-hepatitis-B-virus
- An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity
- Evrys SIRT2 Modulator Promotes Death of HCMV-Infected Monocytes, August 2023”.
- Evrys SIRT2 Allosteric Modulator with Broad-Spectrum Antiviral Activity, June 2023”.
- EvrysBio Science Update at BioCentury 2025 Chicago
- Structural basis for sirtuin 2 activity and modulation: Current state and opportunities
- News
- Contact Us
- Evrys Bio Slide Deck
- Jobs
Evrys Bio
3805 Old Easton Road
Doylestown, PA 18902
Federal Conflict of Interest Policy Statement
